Why Has NAD+ Become Such a Big Part of the Aging Conversation?
You've probably seen the claim:
"NAD+ declines as you age."
And not far behind it:
"Take NMN to restore it."
The actual research is more interesting and more complicated.
NAD+ is an essential molecule involved in cellular metabolism, energy production and signaling.
NMN nicotinamide mononucleotide is one of the molecules your body can use to make NAD+.
That relationship has made NMN an important subject of healthy-aging research.
But researchers aren't simply asking whether NMN can raise a number on a blood test.
The bigger question is:
If NMN changes NAD+ metabolism, does that translate into meaningful changes in how humans function and age?
Human trials have started answering parts of that question.
Other parts remain surprisingly uncertain.
What Is NAD+?
NAD+ stands for nicotinamide adenine dinucleotide.
It's a coenzyme found throughout the body and is required for fundamental cellular processes.
One of its best-known roles involves redox reactions reactions that allow cells to transfer electrons as nutrients are metabolized.
In simplified terms:
But NAD+ isn't simply an "energy molecule."
It also serves as a substrate for enzymes involved in cellular signaling and regulation.
These include:
- Sirtuins
- PARPs
- CD38 and related enzymes
Through these pathways, NAD+ biology intersects with processes involving DNA repair, cellular stress responses, metabolism and mitochondrial function.
That's why NAD+ has become so interesting to aging researchers.
Does NAD+ Actually Decline With Age?
This is where the common longevity narrative needs more context.
Evidence from cells and animal models has strongly influenced the idea that NAD+ availability declines with aging.
Human evidence is less straightforward.
A 2025 Nature Metabolism review concluded that consistent age-associated NAD+ decline in humans had only been demonstrated in a limited number of studies, with substantial gaps in our understanding of how NAD+ changes across different human tissues.
Then, in 2026, researchers examined NAD+ across seven independent human cohorts using a validated analytical method.
Their finding was striking:
Whole-blood NAD+ remained remarkably stable with age.
The authors concluded that whole-blood NAD+ may therefore have limited usefulness as a general biomarker of aging.
That doesn't mean NAD+ biology is irrelevant to aging.
It means the statement:
"Your NAD+ automatically falls as you get older"
is too simplistic.
A more accurate interpretation is:
NAD+ metabolism is involved in aging biology, but how NAD+ availability changes with age may depend on the tissue, biological context and measurement method.
Read the 2026 human NAD+ study on PubMed
So Why Study NMN?
NMN stands for nicotinamide mononucleotide.
It's a naturally occurring intermediate involved in NAD+ biosynthesis.
One of the pathways can be simplified as:
An enzyme called NMNAT converts NMN into NAD+.
This is why NMN is described as an NAD+ precursor.
Researchers can therefore administer NMN and ask:
Does NMN change NAD+ or NAD-related metabolites?
And then:
If it does, does that change anything meaningful about human physiology?
The first question has increasingly been answered.
The second remains much more complicated.
What Do Human NMN Trials Actually Measure?
A good NMN trial doesn't simply ask participants:
"Do you feel younger?"
Researchers use specific endpoints.
Depending on the study, these can include:
NAD+ and NAD-related metabolites
Researchers can measure whether NMN supplementation actually engages the biological pathway it is supposed to influence.
Physical performance
Studies have measured outcomes including:
- Walking speed
- Grip strength
- Stepping performance
- Six-minute walking distance
- Exercise capacity
Muscle function
Some trials have investigated muscle strength, insulin sensitivity or other aspects of skeletal-muscle physiology.
Metabolic outcomes
Researchers may examine:
- Blood glucose
- Insulin sensitivity
- Lipids
- Body composition
- Blood pressure
Sleep and fatigue
Some trials have included questionnaires or other measures related to sleep quality, fatigue and daily function.
Safety
Researchers also monitor adverse events and laboratory markers to evaluate short-term tolerability.
This distinction matters because increasing NAD+ and improving a meaningful health outcome are two separate questions.
What Has Human Research Found?
One randomized, double-blind, placebo-controlled study published in 2024 investigated 250 mg of NMN per day for 12 weeks in 60 older adults.
Researchers measured blood NAD metabolites, motor function and sleep-related outcomes.
After 12 weeks, the NMN group had significantly higher blood NAD+ and related metabolites.
The researchers also reported a shorter 4-meter walking time compared with placebo and improvements in some sleep-quality measures.
But there's an important detail.
The study's primary stepping-test outcome showed no significant difference between NMN and placebo at either four or 12 weeks.
That means the study produced interesting secondary findings, but not a uniformly positive result across its endpoints.
Read the 2024 NMN trial on PubMed
What Does the Bigger Body of Evidence Say?
Looking at individual studies can be useful.
But systematic reviews help us understand whether the pattern holds across multiple trials.
A 2026 systematic review examined 113 eligible studies, including 33 human intervention studies involving NAD-related compounds.
Its conclusion provides a useful summary of where the field currently stands.
In humans, oral NMN and nicotinamide riboside generally demonstrated biochemical target engagement meaning they could change circulating or cellular NAD-related metabolites.
They were also generally well tolerated over the short durations studied.
However, results involving functional, metabolic, vascular and other healthspan-related outcomes were heterogeneous, endpoint-specific and often null.
The authors concluded that the clinical effectiveness of NAD+ augmentation for anti-aging or wellness outcomes remains inconclusive.
That's an important distinction:
Changing NAD-related biomarkers → increasingly established
Producing meaningful anti-aging outcomes → not established
What About NMN Safety?
Human NMN studies so far have generally been relatively short.
A 2026 systematic review and meta-analysis evaluated randomized trials using oral NMN or NMN-related preparations.
Across included studies, doses ranged from 250 to 2,000 mg per day, with study durations ranging from 14 days to 24 weeks.
The analysis did not find a clear increase in overall adverse events, serious adverse events, withdrawals because of adverse events or liver-enzyme abnormalities.
But the researchers also emphasized the need for larger and longer trials to establish long-term safety and efficacy.
So the responsible takeaway isn't:
"NMN is proven safe forever."
It's:
Short-term human trials have generally reported favorable tolerability, while long-term safety remains less established.
What Has NMN Not Been Proven to Do?
Despite the excitement surrounding NAD+ research, human evidence has not established that NMN:
- Reverses human aging
- Extends human lifespan
- Prevents age-related disease
- Makes everyone feel more energetic
- Improves cognitive performance in everyone
- Restores every tissue to a younger NAD+ state
- Produces the same outcome at every dose
- Replaces exercise, sleep or good nutrition
The 2025 clinical review also highlighted uncertainties around tissue-specific responses, clinical efficacy and translation of animal findings into humans.
That's why NMN remains a research topic rather than a proven treatment for aging.
Does More NMN Mean Better Results?
Not necessarily.
Supplement marketing can make dosage look like a simple competition:
250 mg → 500 mg → 1,000 mg → therefore more must be better.
Biology doesn't always work that way.
Different human trials have used different doses, populations, durations and outcome measures.
Researchers are still investigating the optimal dose, frequency, long-term safety and individual variability of NAD+-targeting approaches.
A larger number on a supplement label therefore shouldn't automatically be interpreted as greater effectiveness.
The better question is:
What dose does the product provide, and how does that compare with doses actually investigated in human research?
What Should You Look for in an NMN Product?
If you're comparing NMN supplements, start with information you can actually verify.
1. How Much NMN Does It Provide?
Look for the amount per serving, not simply the number printed most prominently on the packaging.
Then check the recommended serving size.
2. What Form of NMN Is Used?
Published human research frequently refers to β-nicotinamide mononucleotide (β-NMN).
The product label should clearly identify what you're taking.
3. What Else Is in the Formula?
Check the complete ingredient list.
Don't assume two products labelled "NMN" contain identical formulations.
4. What Quality Information Is Available?
Look for specific information regarding:
- Manufacturing standards
- Ingredient specifications
- Purity
- Potency
- Third-party testing, where applicable
Statements such as "premium quality" mean much less than verifiable product information.
5. Does the Company Separate Ingredient Research From Product Claims?
This is particularly important.
A human study investigating NMN does not automatically prove that every commercial NMN product will reproduce that study's results.
Dose, formulation, participant population and study duration all matter.
Transparency is more valuable than an exaggerated promise.
Where Does Aeternum NMN Fit?
Aeternum NMN is designed for people who want to explore NMN as part of the developing research around NAD+ metabolism and healthy aging.
The reason to investigate NMN isn't that science has proven it can reverse aging.
It hasn't.
The reason is that NMN has a clear biological relationship with NAD+ metabolism and has progressed into multiple human clinical trials.
When evaluating Aeternum NMN, we encourage you to look at the same things you should examine with any NMN product:
The research should inform the product decision — not be replaced by marketing claims.
Should You Take NMN?
That's a different question from:
"Is NMN scientifically interesting?"
The answer to the second question is clearly yes.
NMN provides researchers with a way to investigate NAD+ metabolism in humans, and trials have demonstrated biological activity.
Whether supplementation makes sense for an individual depends on factors that a blog article can't determine, including health status, medications, other supplements and personal goals.
If you have a medical condition, take medication, are pregnant or breastfeeding, or have concerns about starting a new supplement, discuss it with an appropriate healthcare professional.
The Bottom Line
The NMN story has become more nuanced as human research has improved.
NAD+ is unquestionably important to cellular biology.
NMN is unquestionably involved in NAD+ biosynthesis.
Human studies show that NAD+ precursors can change NAD-related biomarkers.
But newer human evidence also challenges the idea that whole-blood NAD+ simply declines with chronological age, and trials have not established that raising NAD-related biomarkers automatically translates into broad anti-aging benefits.
That gives us a much more useful research pathway:
NAD+ biology
↓
NMN as a precursor
↓
Changes in NAD-related biomarkers
↓
Human clinical endpoints
↓
Do those changes improve meaningful health outcomes?
That final step is what researchers are still working to understand.
And that's why NMN remains one of the most interesting — but still evolving — areas of healthy-aging research.
Explore NMN Research and Product Information
Want to go deeper before deciding whether NMN belongs in your routine?
Explore the human NMN research →
Review clinical studies examining NAD+ levels, physical function, sleep, metabolism and safety.
Then compare the evidence with the actual product you're considering.
Explore Aeternum NMN product information →
Review the formulation, NMN amount per serving, recommended use and available quality information before making your decision.
Have questions about Aeternum NMN or how its product specifications compare with published research?
Research Featured in This Article
Morifuji M, Higashi S, Ebihara S, Nagata M. (2024).
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study.
GeroScience. PMID: 38789831.
View the clinical trial on PubMed
Vinten KT, et al. (2025).
NAD+ precursor supplementation in human ageing: clinical evidence and challenges.
Nature Metabolism. PMID: 41083806.
Trętowicz MM, et al. (2026).
Human whole-blood NAD+ levels do not vary with age or lifestyle interventions.
Nature Metabolism. PMID: 42135539.
Gallagher C, Emmanuel OO. (2026).
NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence.
Ageing Research Reviews. PMID: 41655607.